PadilhaM.D.M., MeloF.T. de V., LaurentinoR.V., MonteiroJ.C., SilvaA.N.M.R. da, MatosF.S. da S., VianaV.B. de J., AlmeidaJ.L.N., GonçalvesJ.S.S. and FeitosaR.N.M. 2024. Hepatocarcinoma in HBV infection is controlled by the use of entecavir, interferon and tenofovir: viral suppression and restoration of hepatic decompensation. Revista Eletrônica Acervo Científico. 47, (May 2024), e16415. DOI:https://doi.org/10.25248/reac.e16415.2024.